CINECA IRIS Institutional Research Information System

MATTIELLO, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.860
AS - Asia 1.895
EU - Europa 1.583
SA - Sud America 340
AF - Africa 38
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.792
SG - Singapore 851
CN - Cina 633
BR - Brasile 276
IE - Irlanda 249
DE - Germania 246
FI - Finlandia 219
UA - Ucraina 209
IT - Italia 157
VN - Vietnam 150
KR - Corea 138
FR - Francia 136
SE - Svezia 131
GB - Regno Unito 89
PL - Polonia 60
CA - Canada 43
AT - Austria 39
AR - Argentina 27
IN - India 24
BD - Bangladesh 20
HK - Hong Kong 18
SN - Senegal 17
EC - Ecuador 13
MX - Messico 13
ID - Indonesia 11
IQ - Iraq 11
JP - Giappone 11
GR - Grecia 9
ZA - Sudafrica 9
BE - Belgio 8
CO - Colombia 8
NL - Olanda 8
RU - Federazione Russa 7
MA - Marocco 5
NP - Nepal 5
CL - Cile 4
CR - Costa Rica 4
PK - Pakistan 4
UY - Uruguay 4
ES - Italia 3
FJ - Figi 3
HN - Honduras 3
IR - Iran 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
CH - Svizzera 2
EG - Egitto 2
GI - Gibilterra 2
JM - Giamaica 2
JO - Giordania 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
Totale 6.724
Salva come PNG Salva come JPEG
Città #
Beijing 485
Singapore 449
Santa Clara 376
Dublin 248
Chandler 221
Ashburn 137
Jacksonville 136
Buffalo 106
Medford 103
Los Angeles 99
Villeurbanne 99
Princeton 94
Ann Arbor 88
Wilmington 84
Torino 70
Dallas 69
Dearborn 69
Nyköping 67
Houston 64
Columbus 61
Warsaw 57
Fairfield 51
Fremont 51
Ho Chi Minh City 48
Munich 47
The Dalles 43
Boston 35
New York 33
Vienna 33
Milan 28
Hanoi 27
Lachine 20
Turku 20
Helsinki 19
São Paulo 19
Woodbridge 19
Dong Ket 17
Hong Kong 17
Verona 16
Guangzhou 15
Norwalk 15
Seattle 12
Toronto 12
Cambridge 10
Falls Church 10
Hefei 10
Kunming 10
Nuremberg 10
Athens 9
Falkenstein 9
Frankfurt am Main 9
Philadelphia 9
Brussels 8
Nanjing 8
Pisa 8
Boardman 7
Curitiba 7
Seoul 7
Tokyo 7
Belo Horizonte 6
Biên Hòa 6
Brooklyn 6
Chennai 6
Nanchang 6
Pasadena 6
Phoenix 6
Porto Alegre 6
Shanghai 6
Campinas 5
Denver 5
Guayaquil 5
London 5
Pune 5
Quận Bình Thạnh 5
Redondo Beach 5
Rio de Janeiro 5
San Francisco 5
Shenyang 5
Atlanta 4
Baghdad 4
Brasília 4
Caxias do Sul 4
Da Nang 4
Fortaleza 4
Jakarta 4
Jinan 4
Monmouth Junction 4
Montevideo 4
Orem 4
Redwood City 4
Zhengzhou 4
Amsterdam 3
Chicago 3
Detroit 3
Guarulhos 3
Haiphong 3
Oklahoma City 3
Ottawa 3
Resistencia 3
Rome 3
Totale 4.100
Salva come PNG Salva come JPEG
Nome #
NPY-Y1 coexpressed with NPY-Y5 receptors modulate anxiety but not mild social stress response in mice 228
High glucose reduces the anti-aggregating effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 168
A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress. 161
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 124
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. 119
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. 117
High glucose reduces the anti-aggreganting effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 117
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 116
Aspirin resistant subjects present a proinflammatory milieu with an increased oxidative stress: in these conditions, high glucose fails to influence platelet responses to agonists. 115
Glucagon-Like Peptide 1 reduces platelet activation: effects on PI-3K and MAPK pathways and oxidative stress in the presence of arachidonic acid. 111
Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. 109
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 109
Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood 108
Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. 108
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance 108
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets. 108
Effect of dopamine on adenosine 3',5'-cyclic monophosphate levels in human platelets. 107
GLP-1 reduces the activation of PI3K and MAPK pathways and of oxidative stress induced by Na-arachidonate in platelets. 107
Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. 104
Il miglioramento del controllo glicemico riduce la resistenza piastrinica all'aspirina nei pazienti affetti da diabete di tipo 2 104
Arginine vasopressin release from human platelets after irreversible aggregation. 102
Glucagon-Like Peptide 1 reduces platelet activation induced by sodium arachidonate through the inhibition of PI-3K and MAPK pathways. 99
A short-term improvement of blood glucose control increases aspirin sensitivity in aspirin-resistant type 2 diabetic men. 97
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. 96
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus 95
A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents 94
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 94
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus 94
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. 93
An intensive control of blood glucose improves platelet sensitivity to aspirin in type 2 diabetes mellitus. 93
L'acido oleico incrementa trascrizione, sintesi e secrezione del VEGF in cellule muscolari lisce vascolari aortiche: ridotto effetto in condizioni di insulino-resistenza 92
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 90
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 90
Desensitization of the platelet aggregation response to adrenaline during insulin-induced hypoglycaemia in man. 89
A Platelet Defect Characterised by Absent Adrenaline-induced Aggregation and Lack of Secondary Aggregation in Response to ADP and Platelet-activating Factor. 88
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. 88
Acido oleico e regolazione del VEGF in cellule muscolari lisce vascolari aortiche in condizioni di insulino-sensibilità e insulino-resistenza. 88
GLP-1 influences the inhibitory effects of nitric oxide on platelets. 87
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling 86
GLP-1 and liraglutide increase the platelet inhibitory effects of nitric oxide. 85
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus. 85
Il GLP-1 aumenta l'effetto inibitorio dell'ossido nitrico sulle piastrine con meccanismo GLP-1R indipendente. 83
Influence of oleic acid on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells: signalling molecules involved and role of insulin resistance 79
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 79
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways 74
Interplay between milrinone and adenosine in the inhibition of human platelet response. 74
Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. 73
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. 70
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. 69
Influenza dell’alto glucosio sull’aggregazione piastrinica in soggetti aspirino-trattati. 69
The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents 68
Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. 68
Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets. 67
Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells. 66
Non-HDL cholesterol is a determinant of aspirin-resistance in type 2 diabetes mellitus. 65
Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. 64
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects. 64
Studies on inhibition of human platelet response by diltiazem. 63
Insulin stimulates the polymorphonuclear leukocyte chemokinesis. 63
Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. 63
Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3':5'-cyclic monophosphate and adenosine 3':5'-cyclic monophosphate concentrations. 63
Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production. 63
Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. 62
Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. 62
Intrahepatic exIntrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon. 62
Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects 61
Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations. 61
The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide. 61
Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate 60
Glyceryl trinitrate enhances the adenosine-induced inhibition of platelet responses: a mechanism potentially involved in the in vivo anti-aggregating effects of organic nitrates. 60
L-arginine modulates aggregation and intracellular cyclic 3',5'-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative agent. 57
Studies on the effect of dopamine on the human platelet response. 57
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity 57
Insulin influences the renin-angiotensin-aldosterone system in humans. 56
Influence of protamine on adhesion, chemotaxis and proliferation of human vascular smooth muscle cells. 55
Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeptide secretion in man. 54
Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects. 53
Impaired insulin-induced platelet anti-aggregating effect in obesity and in obese non-insulin-dependent diabetes mellitus 52
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost 50
Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control. 50
Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. 48
Modulation of human platelet function by L-canavanine. Differentail effects of low and high concentrations 48
Totale 6.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.149
article - articoli 0
book - libri 0
conference - conferenze 6.352
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021208 0 0 0 0 0 8 28 1 89 39 14 29
2021/2022471 13 9 8 10 8 6 13 19 11 37 154 183
2022/2023760 105 52 22 30 72 249 86 41 66 15 19 3
2023/2024280 29 61 10 18 18 47 1 2 0 7 24 63
2024/20251.613 2 173 43 71 534 78 16 60 152 62 80 342
2025/20261.283 315 88 294 223 323 40 0 0 0 0 0 0
Totale 6.946